Fractional leadership is a part-time executive arrangement. A seasoned leader works with a company for a defined scope and a set number of days each month, without joining as a full-time employee. The person is not a contractor filling a task list and is not a consultant who drops in with a slide deck. They hold real decision rights for a function, then leave capacity for other clients or other work.
The model has become more common in biotech and medical device companies that need senior judgment before they can justify, or afford, a full-time seat. It is also used when a company needs a function stood up quickly and does not yet know what the permanent role should look like.
This post explains what the arrangement includes, when it fits, and where it tends to fail.
What It Is and What It Is Not
A fractional leader typically owns a function at the director, VP, or C level for a portion of their time. Common examples are a fractional chief medical officer, head of quality, head of regulatory, head of manufacturing or CMC, head of clinical operations, or chief people officer. Time commitments often fall between one and three days a week, or a set number of days per month, for six to eighteen months.
The work usually includes setting strategy for that function, representing the company with agencies or partners when needed, building or coaching a small internal team, and making the calls that a junior hire cannot make. The person should be close enough to the operation to be accountable, not so distant that they only review documents.
It is not the same as:
– A contract specialist who executes a work package
– An advisor who attends board meetings and has no operating role
– An interim executive who is full-time for a short period while a search runs
– A fractional arrangement in name only, where the company expects five days of work for two days of pay
Those other models are useful. They are just different. Mixing them up is how companies end up disappointed.
Why Companies Use It
Three situations show up again and again.
- The company needs the function before it can fund the seat. A clinical stage biotech may need medical leadership for protocol design, safety oversight, and investor diligence long before a full time CMO is in the budget. A medtech firm preparing a 51full-timeMA may need regulatory leadership two days a week rather than a full-time VP.
- The company does not yet know the shape of the permanent role. A first manufacturing lead, first quality system owner, or first commercial medical lead often changes after six months of real work. Fractional time lets the organization learn what the job is before locking a full-time hire.
- The company has a gap that is too senior for a contractor and too early for a search. A quality head leaves. An inspection is twelve months out. A full retained search may take four to six months. A fractional leader can stabilize the function, hire the next layer, and help define the permanent profile.
- Budget is part of the story, but it is not the whole story. A strong fractional executive is not cheap on a daily basis. The savings come from buying the right altitude of help without carrying a full year of salary, bonus, equity, and benefits before the need is proven.
Where It Works Best
Fractional leadership works when the scope is clear and the company can make decisions without the person in the building every day.
It tends to fit:
- Quality and regulatory leadership in early and mid-stage companies
- Medical and clinical leadership before a large development organization exists
- CMC or manufacturing leadership during tech transfer, CDMO oversight, or site selection
- Finance, people, or program leadership in companies that are scaling past founder-led operations
- Board-facing functions where credibility matters more than headcount
It works less well when the job is almost entirely on the floor. Day to day batch release decisions, constant shop floor presence, or running a large clinical operations machine usually need a full-time owner. Fractional time can support those environments. It rarely replaces the person who must be there.
Medtech and biotech use the model in slightly different ways. Device companies often bring in fractional regulatory, quality, and clinical affairs leaders around submissions and launches. Biotech companies more often use fractional medical, CMC, and development operations leaders between financing events.
What Good Governance Looks Like
The arrangement fails most often because the company treats it as informal.
Write down:
Days per month and response expectations between those days
- Decision rights versus advisory input
- Who the person reports to
- Which meetings they must attend
- What “done” looks like at 90 days and at six months
- Whether they may work with competitors and how conflicts are handled
- Whether the path includes helping hire their full-time successor
Access matters as much as the contract. A fractional quality leader who cannot see deviations, CAPAs, and training records cannot do the job. A fractional CMO who is kept out of safety discussions is an advisor, not a leader.
Internal communication matters too. Teams need to know this person can say yes and no. If every recommendation must be re-litigated by a founder or a board member, the model adds cost without adding speed.
How It Compares With Other Options
**Versus a contractor:** A contractor is usually hired to complete defined deliverables. A fractional leader is hired to run a function. If you need a protocol written, use a contractor. If you need someone to decide what the development organization should look like, use fractional leadership or a full-time hire.
**Versus an interim executive:** Interims are typically full-time and short. They are the right tool when the seat cannot be empty, and a search is already underway. Fractional leadership is the right tool when the company needs senior capacity at less than full time, often for longer than a classic interim stint.
**Versus a full-time executive search:** Search is the right path when the role is clearly permanent, the team needs a daily leader, and the company can recruit and retain at market. Fractional leadership is a bridge or a test. It is not a permanent substitute for a core C-level seat in a company that has reached that scale.
Many companies use the models in sequence. Fractional leader stands the function up. Contractors fill specialized gaps. A direct hire search begins once the scope is proven.
What Candidates Should Understand
Experienced leaders take these roles for different reasons. Some want variety. Some are between full-time seats. Some prefer a portfolio of companies after a long stretch in one organization.
The work is not lighter just because it is part time. The leader still carries reputation risk, especially in quality, safety, and regulatory. They need enough access and authority to stand behind the work. They also need the company to respect the time boundary. Scope creep is the usual point of friction.
For the company, that means being honest in the first conversation. If the job will take four days a week, do not sell it as two. If conversion to full time is possible, say so. If it is not, say that too.
Risks to Watch
The main risks are predictable.
The company under-scopes the time and then resents the leader for not being available. The leader accepts too many clients and cannot respond when an inspection letter or safety issue appears. Intellectual property, confidentiality, and conflict terms are left vague. The organization delays a necessary full-time hire because the fractional arrangement feels good enough.
There is also a cultural risk. Employees may not know whether to treat the person as their boss. Customers, CDMOs, and regulators may ask who actually owns the function. Clear titles and clear internal messaging reduce that confusion.
None of these risks mean the model is flawed. They mean it needs the same discipline as any other executive appointment.
When to Move On
Fractional leadership should have an exit in mind, even if the date is flexible.
Move to a full-time search when the function is busy enough that part-time coverage creates delays, when inspections or launches need a daily owner, or when investors and partners expect a dedicated executive. Stay fractional when the work remains bursty, the company is still shaping the role, or the next financing event will change the org chart anyway.
The useful question is not “Do we believe in fractional leadership?” The useful question is “What does this function need from a leader over the next two quarters, and how much of that person’s week do we actually require?”
Answer that plainly. Then choose the model that matches the work.
With over 1000 engagements under our belts, GForce Life Sciences has extensive experience supporting biotech, pharma, and medical device clients identify fractional leadership. If your team is considering how to fill gaps in their leadership structure, please contact us today.